Business Name: |
Lindemann Matthew MD |
Contact Person: |
Matthew Lindemann |
Address: |
4001 Dale St # 105, Anchorage, Alaska 99508 |
Phone Number: |
(907) 222-9930 |
Website Address: |
denaliobgyn.com |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Mark Richey MD - Anchorage, AK 99508 Mills III William J MD - Anchorage, AK 99508 Monroe Gary MD - Anchorage, AK 99508 Evans Justin MD - Anchorage, AK 99508 Diu Michelle MD - Anchorage, AK 99508 Scofield Kirk MD - Anchorage, AK 99508 Tan Christine MD - Anchorage, AK 99508 Biggs Russell E MD - Anchorage, AK 99508 Bell Darin M MD - Anchorage, AK 99508 Ostrom Kathryn MD - Anchorage, AK 99508 Linden Leslie MD - Anchorage, AK 99508 Powell Elisha T MD - Anchorage, AK 99508 Harrison Thomas J MD - Anchorage, AK 99508 Mc Cormick Julie MD - Anchorage, AK 99508 Love Jenny G MD - Anchorage, AK 99508 Saprykina Natalia MD - Anchorage, AK 99508 Bertrand Susan True MD - Anchorage, AK 99508 Grendahl Marvin J MD - Anchorage, AK 99508 Tappel John MD - Anchorage, AK 99508 Lyon W Jon MD - Anchorage, AK 99508 |
The company Lindemann Matthew MD provides B2C services in the form of Doctors from its single location in Alaska.
1 to 4 employees work for Lindemann Matthew MD, and the business now earns $500.000 to $999.999 per annum.
Lindemann Matthew MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Lindemann Matthew MD, please call Matthew Lindemann with the phone number (907) 222-9930 or visit its single location at 4001 Dale St # 105 in Anchorage, Alaska 99508.
The location of the single location can also be found using the coordinates 61.184137,-149.817643.
Read more details about this business on the webpage denaliobgyn.com or follow the company’s social media accounts, on Twitter and on Facebook.